Clinical Trials Browser

Gastro-enteropancreatic neuroendocrine tumor × Lutetium-177 × 90 days × Clear all

NCT04711135 2026-02-12

NETTER-P

Phase 2 Active not recruiting

11 enrolled 14 charts 1 FDA

CNSEndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Paraganglioma, Pheochromocytoma